SRPT
Sarepta Therapeutics Inc
Price:  
128.92 
USD
Volume:  
1,160,484.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRPT WACC - Weighted Average Cost of Capital

The WACC of Sarepta Therapeutics Inc (SRPT) is 7.3%.

The Cost of Equity of Sarepta Therapeutics Inc (SRPT) is 7.60%.
The Cost of Debt of Sarepta Therapeutics Inc (SRPT) is 4.55%.

Range Selected
Cost of equity 6.20% - 9.00% 7.60%
Tax rate 0.20% - 0.90% 0.55%
Cost of debt 4.00% - 5.10% 4.55%
WACC 6.0% - 8.6% 7.3%
WACC

SRPT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.5 0.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.20% 9.00%
Tax rate 0.20% 0.90%
Debt/Equity ratio 0.1 0.1
Cost of debt 4.00% 5.10%
After-tax WACC 6.0% 8.6%
Selected WACC 7.3%